Latest & greatest articles for corticosteroids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on corticosteroids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on corticosteroids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for corticosteroids

1. Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study Full Text available with Trip Pro

Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose (...) a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} A full trial is likely to be feasible to compare different corticosteroid induction regimes, taking account of the views of the children, young people and families when designing a future study. {{author}} {{($index , , , , , , , , , , , , , , & . Ashley P Jones 1 , Dannii Clayton 1 , Gloria Nkhoma 1 , Frances

2020 NIHR HTA programme

2. Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest (...) there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation J Clin Med Actions . 2020 Jul 27;9(8):E2392. doi: 10.3390/jcm9082392. Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis

2020 EvidenceUpdates

3. COVID-19: Corticosteroids for hospitalized patients

COVID-19: Corticosteroids for hospitalized patients COVID-19: SYSTEMIC CORTICOSTEROIDS FOR HOSPITALIZED PATIENTS A Rapid Guidance Summary from the Penn Medicine Center for Evidence-based Practice Last updated July 27, 2020. All links rechecked July 27 unless otherwise noted. This Rapid Guidance Summary is a description of existing guidance and evidence reviews from a variety of sources that was in effect at the time of publication. It should not be used or interpreted as a clinical practice (...) guideline, but instead can be used in development of local recommendations and policies. Key questions answered in this summary • How should corticosteroid drugs be used in patients with severe COVID-19 disease? Management of patients who are taking corticosteroids for chronic conditions, use of inhaled corticosteroids, and treatment of patients who are pregnant is outside the scope of this report. Summary of major recommendations • Most recent clinical practice guidelines are now consistently

2020 Centre for Evidence-Based Practice, Penn Medicine

4. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants

Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants Historically, postnatal corticosteroids have been used to prevent and treat bronchopulmonary dysplasia (BPD), a significant cause of morbidity and mortality in preterm infants. Administering dexamethasone to prevent BPD in the first 7 days post-birth has been associated with increasing risk for cerebral palsy, while early inhaled corticosteroids appear to be associated with an increased risk of mortality (...) post-birth, clinicians may consider a short course of low-dose dexamethasone (0.15 mg/kg/day to 0.2 mg/kg/day) for individual infants at high risk for, or with evolving, BPD. There is no evidence that hydrocortisone is an effective or safe alternative to dexamethasone for treating evolving or established BPD. Current evidence does not support inhaled corticosteroids for the treatment of BPD.  Keywords: Bronchopulmonary dysplasia (BPD); Dexamethasone; Hydrocortisone; Inhaled

2020 Canadian Paediatric Society

5. Ultrasound-Guided Corticosteroid Injection in Carpal Tunnel Syndrome: Comparison Between Radial and Ulnar Approaches Full Text available with Trip Pro

Ultrasound-Guided Corticosteroid Injection in Carpal Tunnel Syndrome: Comparison Between Radial and Ulnar Approaches Ultrasound-Guided Corticosteroid Injection in Carpal Tunnel Syndrome: Comparison Between Radial and Ulnar Approaches - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation J Pain Res Actions . 2020 Jun 26;13:1569-1578. doi: 10.2147/JPR.S248600. eCollection 2020. Ultrasound-Guided Corticosteroid Injection in Carpal Tunnel Syndrome: Comparison Between Radial and Ulnar

2020 EvidenceUpdates

6. Should You Recommend Inhaled Corticosteroids for This Patient With Chronic Obstructive Pulmonary Disease?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. (Abstract)

Should You Recommend Inhaled Corticosteroids for This Patient With Chronic Obstructive Pulmonary Disease?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Approximately 12 million adults in the United States receive a diagnosis of chronic obstructive pulmonary disease (COPD) each year, and it is the fourth leading cause of death. Chronic obstructive pulmonary disease refers to a group of diseases that cause airflow obstruction and a constellation of symptoms, including cough (...) bronchodilators, whereas the role of inhaled corticosteroids is less clear. Inhaled corticosteroids have substantial risks, including an increased risk for pneumonia. Here, 2 experts, both pulmonologists, reflect on the care of a woman with severe COPD, a 50-pack-year smoking history, frequent COPD exacerbations, and recurrent pneumonia. They consider the indications for inhaled corticosteroids in COPD, when inhaled corticosteroids should be withdrawn, and what other treatments are available.

2020 Annals of Internal Medicine

7. COVID-19: Corticosteroids for hospitalized patients

COVID-19: Corticosteroids for hospitalized patients COVID-19: CORTICOSTEROIDS FOR HOSPITALIZED PATIENTS A Rapid Guidance Summary from the Penn Medicine Center for Evidence-based Practice Last updated June 8, 2020. All links rechecked June 8 unless otherwise noted. This Rapid Guidance Summary is a description of existing guidance and evidence reviews from a variety of sources that was in effect at the time of publication. It should not be used or interpreted as a clinical practice guideline (...) , but instead can be used in development of local recommendations and policies. Key questions answered in this summary • How should corticosteroid drugs be used in patients with severe COVID-19 disease? Management of patients who are taking corticosteroids for chronic conditions and treatment of patients who are pregnant is outside the scope of this report. Summary of major recommendations • Guidelines recommend against routine use of corticosteroids in patients with COVID-19 disease. • Guidelines weakly

2020 Centre for Evidence-Based Practice, Penn Medicine

8. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis Full Text available with Trip Pro

Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis Efficacy and Safety of Corticosteroids in COVID-19 Based on Evidence for COVID-19, Other Coronavirus Infections, Influenza, Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript (...) ? Report format: Send at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation CMAJ Actions . 2020 May 14;cmaj.200645. doi: 10.1503/cmaj.200645. Online ahead of print. Efficacy and Safety of Corticosteroids in COVID-19 Based on Evidence for COVID-19, Other

2020 EvidenceUpdates

9. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature Full Text available with Trip Pro

Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center (...) Link Copy Actions Cite Share Permalink Copy Page navigation Front Med (Lausanne) Actions . 2020 Apr 24;7:170. doi: 10.3389/fmed.2020.00170. eCollection 2020. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy. 2 Clinical and Experimental Medicine PhD Program, University of Modena

2020 EvidenceUpdates

10. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis Full Text available with Trip Pro

study. Lancet. 2020;395:507–13. doi: 10.1016/S0140-6736(20)30211-7. - - - Sung JJ, Wu A, Joynt GM, Yuen KY, Lee N, Chan PK, et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax. 2004;59:414–20. doi: 10.1136/thx.2003.014076. - - - Show all 25 references Publication types Meta-Analysis Actions Research Support, Non-U.S. Gov't Actions Systematic Review Actions MeSH terms Adrenal Cortex Hormones / therapeutic use* Actions Betacoronavirus / drug effects (...) * Actions Coronavirus Infections / drug therapy* Actions Coronavirus Infections / virology Actions Humans Actions Middle East Respiratory Syndrome Coronavirus / drug effects* Actions Pandemics Actions Pneumonia, Viral / drug therapy* Actions Pneumonia, Viral / virology Actions SARS Virus / drug effects* Actions Severe Acute Respiratory Syndrome / drug therapy* Actions Severe Acute Respiratory Syndrome / virology Actions Substances Adrenal Cortex Hormones Actions Supplementary concepts COVID-19 Actions

2020 EvidenceUpdates

11. Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children. (Abstract)

Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children. Maternal antenatal corticosteroid treatment is standard care to accelerate fetal maturation when birth before 34 weeks is imminent. Recently, expansion of the indications beyond 34 gestational weeks has been debated. However, data about long-term outcomes remain limited, especially among infants who after treatment exposure are born at term.To study if antenatal corticosteroid (...) December 31, 2017.Maternal antenatal corticosteroid treatment.Primary outcome was any childhood mental and behavioral disorder diagnosed in public specialized medical care settings.Of the 674 877 singleton children born in Finland during the study period, 670 097 were eligible for analysis. The median length of follow-up was 5.8 (interquartile-range, 3.1-8.7) years. Of the 14 868 (2.22%; 46.1% female) corticosteroid treatment-exposed children, 6730 (45.27%) were born at term and 8138 (54.74%) were born

2020 JAMA

12. Do Corticosteroids Benefit Patients With Influenza Pneumonia? Full Text available with Trip Pro

Do Corticosteroids Benefit Patients With Influenza Pneumonia? Do Corticosteroids Benefit Patients With Influenza Pneumonia? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page To read this article in full, please review your options for gaining access at the bottom of the page. Article in Press Do Corticosteroids Benefit Patients With Influenza Pneumonia? x Michael Gottlieb , MD (EBEM Commentator) , x Thomas Seagraves , MD (EBEM (...) Commentator) , x Stephen R. Gore , MD (EBEM Commentator) Department of Emergency Medicine, Rush University Medical Center, Chicago, IL DOI: Publication History Published online: July 23, 2019 To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Among patients with influenza pneumonia, corticosteroids are associated with increased mortality, longer length of stay in the ICU, and higher rates of secondary infection, although there are no data from

2020 Annals of Emergency Medicine Systematic Review Snapshots

13. Comparing ultrasound-guided needling combined with a subacromial corticosteroid injection versus high-energy extracorporeal shockwave therapy for calcific tendinitis of the rotator cuff. A randomized controlled trial

Comparing ultrasound-guided needling combined with a subacromial corticosteroid injection versus high-energy extracorporeal shockwave therapy for calcific tendinitis of the rotator cuff. A randomized controlled trial Comparing Ultrasound-Guided Needling Combined With a Subacromial Corticosteroid Injection Versus High-Energy Extracorporeal Shockwave Therapy for Calcific Tendinitis of the Rotator Cuff: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Arthroscopy Actions . 2020 Feb 28;S0749-8063(20)30182-1. doi: 10.1016/j.arthro.2020.02.027. Online ahead of print. Comparing Ultrasound-Guided Needling Combined With a Subacromial Corticosteroid Injection Versus High-Energy Extracorporeal Shockwave Therapy for Calcific Tendinitis

2020 EvidenceUpdates

14. Comparison Between Extracorporeal Shock Wave Therapy and Local Corticosteroid Injection for Plantar Fasciitis (Abstract)

Comparison Between Extracorporeal Shock Wave Therapy and Local Corticosteroid Injection for Plantar Fasciitis Extracorporeal shock wave therapy (ESWT) is a nonsurgical treatment for plantar fasciitis (PF) that has had satisfactory clinical outcomes. However, local corticosteroid injection (LCI) is often regarded as first-line treatment of PF, but there have been few studies comparing the 2 methods. Therefore, we compared the effect of ESWT and LCI on patients with PF.This was a block randomized

2020 EvidenceUpdates

15. Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19

Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19 Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19 - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19 June 22, 2020 Laura C Armitage and Rachel Brettell On behalf (...) of the Oxford COVID-19 Evidence Service Team Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences University of Oxford Correspondence to: VERDICT This review aimed to synthesise the current literature on the role of inhaled corticosteroids in moderating the disease course or severity of COVID-19 disease. Inhaled ciclesonide has been shown to suppress SARS-CoV-2 replication in cultured cells and it is suggested that it exhibits direct acting anti-viral activity in addition

2020 Oxford COVID-19 Evidence Service

16. Chronic obstructive pulmonary disease: Inhaled corticosteroids

Chronic obstructive pulmonary disease: Inhaled corticosteroids Inhaled corticosteroids | Prescribing information | Chronic obstructive pulmonary disease | CKS | NICE Search CKS… Menu Inhaled corticosteroids Chronic obstructive pulmonary disease: Inhaled corticosteroids Last revised in November 2019 Inhaled corticosteroids What inhaled corticosteroids are available for COPD, and what dose should I prescribe? Inhaled corticosteroids (ICS) should be prescribed in combination with a long-acting (...) bronchodilator in people with chronic obstructive pulmonary disease (COPD). The NICE guideline on COPD [ ] recommends that where combination therapy with long-acting bronchodilators and ICS is being considered, clinicians should be aware of, and discuss with the person, the risk of adverse effects including an increased risk of pneumonia (which may require hospitalization). Inhaled corticosteroid preparations licensed for the management of COPD are available as combination products. They include: Formoterol

2020 NICE Clinical Knowledge Summaries

17. Seborrhoeic dermatitis: Topical corticosteroids

Seborrhoeic dermatitis: Topical corticosteroids Topical corticosteroids | Prescribing information | Seborrhoeic dermatitis | CKS | NICE Search CKS… Menu Topical corticosteroids Seborrhoeic dermatitis: Topical corticosteroids Last revised in February 2019 Topical corticosteroids For detailed information on prescribing corticosteroids see the CKS topic on . © .

2020 NICE Clinical Knowledge Summaries

18. The Effects of Perioperative Corticosteroids on Dysphagia Following Surgical Procedures Involving the Anterior Cervical Spine: A Prospective, Randomized, Controlled, Double-Blinded Clinical Trial (Abstract)

The Effects of Perioperative Corticosteroids on Dysphagia Following Surgical Procedures Involving the Anterior Cervical Spine: A Prospective, Randomized, Controlled, Double-Blinded Clinical Trial Dysphagia is one of the most common complications of surgical procedures in the anterior cervical spine, and can persist up to 2 years postoperatively. Corticosteroids are relatively safe and inexpensive for treating various inflammatory conditions. Perioperative corticosteroid administration (...) for anterior cervical spine procedures may effectively minimize postoperative dysphagia, potentially leading to better outcomes, decreased readmission rates, and improved patient satisfaction. The purpose of this study was to determine the efficacy of perioperative corticosteroids in decreasing the severity and duration of dysphagia following single-level and multilevel anterior cervical spine procedures.Seventy-four patients undergoing elective anterior cervical surgical procedures for degenerative

2019 EvidenceUpdates

19. Inhaled Corticosteroids for Cystic Fibrosis: A Review of Clinical Effectiveness

Inhaled Corticosteroids for Cystic Fibrosis: A Review of Clinical Effectiveness Inhaled Corticosteroids for Cystic Fibrosis: A Review of Clinical Effectiveness | CADTH.ca Find the information you need Inhaled Corticosteroids for Cystic Fibrosis: A Review of Clinical Effectiveness Inhaled Corticosteroids for Cystic Fibrosis: A Review of Clinical Effectiveness Last updated: March 12, 2019 Project Number: RC1082-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal (...) Result type: Report Question What is the clinical effectiveness of inhaled corticosteroids for the management of patients with cystic fibrosis? Key Message Evidence of limited quality from one systematic review reporting study-level findings and one randomized controlled trial suggested that routine use of inhaled corticosteroids in children and adult cystic fibrosis patients is not significantly more effective than placebo or non-steroid medication in improving lung function as indicated by forced

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

20. Intranasal Corticosteroids for the Management of Chronic Rhinosinusitis or Nasal Polyposis in Cystic Fibrosis: A Review of Clinical Effectiveness

Intranasal Corticosteroids for the Management of Chronic Rhinosinusitis or Nasal Polyposis in Cystic Fibrosis: A Review of Clinical Effectiveness Intranasal Corticosteroids for the Management of Chronic Rhinosinusitis or Nasal Polyposis in Cystic Fibrosis: A Review of Clinical Effectiveness | CADTH.ca Find the information you need Intranasal Corticosteroids for the Management of Chronic Rhinosinusitis or Nasal Polyposis in Cystic Fibrosis: A Review of Clinical Effectiveness Intranasal (...) Corticosteroids for the Management of Chronic Rhinosinusitis or Nasal Polyposis in Cystic Fibrosis: A Review of Clinical Effectiveness Last updated: March 18, 2019 Project Number: RC1083-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of intranasal corticosteroids for the management of chronic rhinosinusitis or nasal polyposis in patients with cystic fibrosis? Key Message One systematic review with one included

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review